Zobrazeno 1 - 10
of 69
pro vyhledávání: '"R. Humeres"'
Autor:
Andrés Navarrete, R. Humeres
Publikováno v:
Cirugía Española. 100:55-57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::859fd85d023138c1776c7e6a8488d667
https://doi.org/10.1016/j.ciresp.2020.09.010
https://doi.org/10.1016/j.ciresp.2020.09.010
Autor:
Carlos Derosas, Franco Innocenti, Blanca Norero, Alvaro Urzúa, R. Humeres, Gabriel Mezzano, Rodrigo Wolff, Claudia Pavez, Susana Elgueta, Lorena Castro, Luis Antonio Díaz
Publikováno v:
Revista médica de Chile v.148 n.11 2020
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: In Chile, organ allocation for liver transplantation (LT) in adults is prioritized according to the MELD-Na score. Exceptions such as Hepatocellular Carcinoma (HCC) and other non-HCC exceptions receive a score called Operational MELD scor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4697eb4369a20a55f511ee4dadb68650
https://doi.org/10.4067/s0034-98872020001101541
https://doi.org/10.4067/s0034-98872020001101541
Autor:
Rodrigo Zapata, Franco Innocenti, Lorena Calabrán, Luis Antonio Díaz, Barbara Lara, Guillermo Silva, José Tomás Ibarra, Alejandra Cancino, R. Humeres, Rodrigo Wolff, Camila Robles, Montserrat Rius, Sandra González, Sergio Álvarez, José L. Rojas, Rosa María Pérez, Bessie Hunter, Blanca Norero, Jaime Poniachik, Susana Elgueta
Publikováno v:
Annals of Hepatology, Vol 18, Iss 2, Pp 325-330 (2019)
Introduction and aim The MELD score has been established as an efficient and rigorous prioritization system for liver transplant (LT). Our study aimed to evaluate the effectiveness of the MELD score as a system for prioritization for LT, in terms of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e34b8e225cf9cfdd270ef8c230fc1fea
https://doi.org/10.1016/j.aohep.2018.11.001
https://doi.org/10.1016/j.aohep.2018.11.001
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R. Humeres, G. Rencoret, O. Maida, G. Cardenas, M. Vivanco, J. Francisco Tabilo, Xabier de Aretxabala
Publikováno v:
HPB. 21:S168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09bfc9809918e09edb854c76df086627
https://doi.org/10.1016/j.hpb.2019.03.305
https://doi.org/10.1016/j.hpb.2019.03.305
Autor:
Rodrigo Zapata, R. Humeres, Maria Marta Rivas, Sebastián Marciano, Marcelo Silva, Angelo Alves de Mattos, Gustavo Kusminsky, Manuel Mendizabal, Luciana dos Santos Schraiber, Maria Lucia Zanotelli, Adrián Gadano, Rodolfo Quiros
Publikováno v:
Clinical Transplantation. 27:E469-E477
Post-transplant lymphoproliferative disorder (PTLD) is a major and potentially life-threatening complication after solid-organ transplantation. The aim of this study was to describe the disease characteristics, clinical practices, and survival relate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0520d026b261f18b02a49aedf279d42
https://doi.org/10.1111/ctr.12152
https://doi.org/10.1111/ctr.12152
Autor:
Rodrigo Zapata, J. Hepp, G. Rencoret, M. Rius, M. Schultz, R. Humeres, H. Rios, E. Sanhueza, M. Vivanco, J. Contreras, J.M. Palacios
Publikováno v:
HPB. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d9549868fd281ef19762af58b16461
Autor:
Rodrigo Zapata, Alejandro Soza, R. Yáñes, Edgar Sanhueza, Eduardo O. Figueroa, Jorge Contreras, Mauricio Gabrielli, Nicolás Jarufe, Marcelo Vivanco, J.M. Palacios, R. Rossi, Marco Arrese, Rosa María Pérez, Jorge Martínez, H. Rios, Juan Francisco Guerra, R. Humeres, G. Rencoret, J. Hepp
Publikováno v:
Transplantation proceedings. 42(1)
Hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver. Liver transplantation is the best treatment for HCC; it improves survival, cures cirrhosis, and abolishes local recurrence. We describe the outcomes of patients with HCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::878b6805a453083657951ab47b962e74
https://pubmed.ncbi.nlm.nih.gov/20172336
https://pubmed.ncbi.nlm.nih.gov/20172336
Autor:
Nicolás Jarufe, E. Sanhueza, J. Contreras, R. Yáñes, R. Humeres, Eduardo O. Figueroa, J.M. Palacios, Jorge Martínez, J. Hepp, Marco Arrese, Alejandro Soza, Mauricio Gabrielli, R. Pérez, R. Rossi, H. Rios, G. Rencore, Juan Francisco Guerra, M. Vivanco, Rodrigo Zapata
Publikováno v:
Transplantation proceedings. 42(1)
Background. Orthotopic liver transplantation (OLT) is currently an established therapy for small, early-stage hepatocellular carcinoma (HCC) within the Milan criteria. Long waiting times due to the shortage of donor organs can result in tumor progres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f634225c6d9ac305049a9eb2e7315e7
https://pubmed.ncbi.nlm.nih.gov/20172335
https://pubmed.ncbi.nlm.nih.gov/20172335
Autor:
Erwin Buckel, J. Hepp, Marco Arrese, Rosa María Pérez, Rodrigo Zapata, E. Sanhueza, Bessie Hunter, Jaime Poniachik, Mario Uribe, R. Humeres, Danny Oksenberg, Mario Ferrario, Jorge Martínez, Juan Carlos Díaz, Gloria Ríos
Publikováno v:
Revista médica de Chile v.136 n.6 2008
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Liver transplantation is an excellent therapeutic option for terminal liver disease. During the last decades the results of liver transplantation have improved significantly with a patient survival rate of nearly 90% at one year and 80% at 5 years of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d1ff14595ec204a30f5f6bcd1b391e5
https://doi.org/10.4067/s0034-98872008000600017
https://doi.org/10.4067/s0034-98872008000600017